3Roth WK,Weber M,Seifried E. Feasibility and efficacy of routine PCR screening of blooddonations for hepatitis C virus,hepatitis B virus, and HIV-1 in a blood-bank setting[J].Lancet, 1999,35 (3): 359-363.
4W. Kur Roth, Marijke, Deteler Petersen. NAT for HBV and anti- HBV testing increase bloodsafety [J]. Transfusion,2002,42(7) :869.
二级参考文献8
1Busch MP,Kleinman SH,Jackson B,et al.Nuclein acid amplification testing of blood donors for transfusion-transmitted infectious diseases[].Transfusion.2000
2Sloand EM,Pitt E,Klein HG.Safety of the blood supply[].The Journal of The American Medical Association.1995
3Busch MP,Rawal BD,Nowicki M,et al.HCV RNA and ALT patterns in seroconverting transfusion recipients and correlation with donor ALT and RNA[].Transfusion.1997
4Vrielink H,Reesink HW,van den Burg PJM,et al.Performance of three generations of anti-hepatitis C virus ELISA in donors and patients[].Transfusion.1997
5Schottstedt V,Tuma W,Bunger G,et al.PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service[].Biologicals.1998
6Schreiber GB,Busch MP,Kleinman SH,et al.The risk of transfusiontransmitted viral infection[].The New England Journal of Medicine.1996
7Roth WK,Weber M,Seifried E.Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting[].The Lancet.1999
8Cardoso MS,Koerner K,Kubanek B,et al.Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results[].Transfusion.1998
